Solid Tumor Malignancies Clinical Trials
43 clinical trials for Solid Tumor Malignancies across international registries, including 21 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies — RECRUITING · PHASE4
- Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE4
- Exploring the Feasibility of Cerebrospinal Fluid (CSF) and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and Primary Central Nervous System (CNS) Tumours: A Pilot Study — RECRUITING · NA
- PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival — RECRUITING · NA
- Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies — RECRUITING · PHASE3
- Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS) — RECRUITING · PHASE1
- A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases — RECRUITING · PHASE1
- A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies — RECRUITING · PHASE1
- xDRIVE for Florida-based Cancer Patients — RECRUITING · NA
- A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies — RECRUITING · PHASE1
- Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors. — RECRUITING · PHASE2
- Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
- A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies — RECRUITING · PHASE1
- Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
- A Study of SH009 Injection in Patients With Advanced Solid Tumors. — RECRUITING · PHASE1
- A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors — RECRUITING · PHASE1
- A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
- A Clinical Study of GO306 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
- A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia — RECRUITING · PHASE1
- A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Previously Treated Cancers — RECRUITING · PHASE2
- A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
- GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
- A Clinical Study of GO321 in Patients With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
- ECMO Use in Pediatric Oncology and HSCT Patients: A Descriptive and Comparative Analysis — COMPLETED
- Clinical Evaluation of [68Ga]Ga-FFD PET Imaging in Healthy Volunteers and Patients With Solid Tumors — NOT_YET_RECRUITING · PHASE1
- A Phase I/II Study of FG-M108 Plus FG-B901 in Advanced CLDN18.2-Positive Solid Tumors — NOT_YET_RECRUITING · PHASE1
- GKL-006Allo Injection in Patients With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
- Imaging Study of [89Zr]DFO-YS5 for Cancer Detection — NOT_YET_RECRUITING · PHASE1
- ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter — TERMINATED · PHASE2
- ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies — COMPLETED · PHASE1
- Exploration Study of Molecular Biomarkers for Tumor-related Anxiety and Depression — NOT_YET_RECRUITING
- Predicting Reactions and Effects of Drugs Immunotherapy and Complications Through Oncosafety (PREDICTO Clinical Study) — NOT_YET_RECRUITING · NA
- Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors — NOT_YET_RECRUITING · PHASE1
- Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
- Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
- Serum IGF-1 and IGF-1Ec in Malignancy Assessment — ACTIVE_NOT_RECRUITING
- 68Ga-GP-01 Injection in Solid Tumors Participants — NOT_YET_RECRUITING · PHASE1
- Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies — COMPLETED · PHASE1
- Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies — TERMINATED · PHASE1
- Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies — COMPLETED · PHASE1
- A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors — COMPLETED · PHASE1
- A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies — TERMINATED · PHASE1
- Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies — TERMINATED · PHASE1
Refine this search